Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
Holders of 5% or more of RVPH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Reviva Pharmaceuticals Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Highbridge Capital Management LLC | 13G | 9.90%8.00M shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| Integrated Core Strategies (US) LLC | 13G | 6.20%794.0K shares | New | Mar 30, 20261 filing | Mar 30, 2026 | SEC |
| 683 Capital Management, LLC | 13G | 5.36%5.43M shares | New | Sep 29, 20251 filing | Sep 29, 2025 | SEC |
| Saxena Parag | 13D/A | 5.20%6.27M shares | −1.00 ppfrom 6.20% | Jan 31, 20254 filings | Dec 22, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
17 Schedule 13D and 13G filings on Reviva Pharmaceuticals Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 20265:34 PM ET | Integrated Core Strategies (US) LLCand 3 others | 13G | 6.20%794.0K shares | New | Mar 23, 2026 | SEC |
| Dec 22, 20254:30 PM ET | Saxena Paragand 1 other | 13D/A | 5.20%6.27M shares | −1.00 ppfrom 6.20% | Dec 18, 2025 | SEC |
| Sep 29, 20256:59 PM ET | 683 Capital Management, LLCand 2 others | 13G | 5.36%5.43M shares | New | Sep 22, 2025 | SEC |
| Sep 24, 20254:33 PM ET | Bhat Laxminarayan | 13D/A | 3.80%3.68M shares | −1.40 ppfrom 5.20%Below 5% | Sep 22, 2025 | SEC |
| Sep 24, 20254:30 PM ET | Saxena Paragand 1 other | 13D/A | 6.20%6.26M shares | −2.50 ppfrom 8.70% | Sep 22, 2025 | SEC |
| Aug 14, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 4.80%3.40M shares | −3.00 ppfrom 7.80%Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20254:08 PM ET | Highbridge Capital Management LLC | 13G | 9.90%8.00M shares | New | Jun 30, 2025 | SEC |
| Aug 14, 20252:01 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 4.90%3.57M shares | −1.00 ppfrom 5.90%Below 5% | Jun 30, 2025 | SEC |
| Jul 1, 20256:40 PM ET | Saxena Paragand 2 others | 13D/A | 8.70%6.26M shares | −3.70 ppfrom 12.40% | Jun 27, 2025 | SEC |
| Jul 1, 20254:30 PM ET | Bhat Laxminarayan | 13D/A | 5.20%3.61M shares | −1.60 ppfrom 6.80% | Jun 27, 2025 | SEC |
| Jul 1, 202510:18 AM ET | CVI Investments, Inc.and 1 other | 13G | 5.90%4.00M shares | +1.00 ppfrom 4.90% | Jun 26, 2025 | SEC |
| May 15, 20254:15 PM ET | Tang Capital Management LLCand 5 others | 13G/A | 7.80%3.91M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20254:16 PM ET | Schonfeld Strategic Advisors LLC | 13G/A | 2.82%1.31M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 7, 20254:10 PM ET | CVI Investments, Inc.and 1 other | 13G/A | 4.90%2.45M shares | −2.30 ppfrom 7.20%Below 5% | Dec 31, 2024 | SEC |
| Jan 31, 20259:31 PM ET | Saxena Paragand 4 others | 13D/A | 12.40%6.27M shares | – | Dec 18, 2024 | SEC |
| Dec 23, 202411:30 AM ET | CVI Investments, Inc.and 1 other | 13G | 7.20%3.33M shares | New | Dec 16, 2024 | SEC |
| Dec 20, 20244:30 PM ET | Bhat Laxminarayan | 13D/A | 6.80%3.20M shares | – | Dec 18, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Reviva Pharmaceuticals Holdings, Inc. shares.
No Form 144 notices for Reviva Pharmaceuticals Holdings, Inc. are on file.